Healthcare provider profile · identity verified

Troy Patrick Kittleson, GNP

Nurse Practitioner · BLOOMINGTON, MN · NPI 1801865084

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	359	43
Trazodone Hcl	Trazodone Hcl	358	46
Mirtazapine	Mirtazapine	331	43
Lisinopril	Lisinopril	329	35
Atorvastatin Calcium	Atorvastatin Calcium	323	37
Omeprazole	Omeprazole	297	33
Donepezil Hcl	Donepezil Hcl	282	32
Levothyroxine Sodium	Levothyroxine Sodium	235	23
Amlodipine Besylate	Amlodipine Besylate	232	32
Metoprolol Succinate	Metoprolol Succinate	219	27
Quetiapine Fumarate	Quetiapine Fumarate	203	26
Furosemide	Furosemide	192	27
Warfarin Sodium	Warfarin Sodium	181	suppressed
Potassium Chloride	Potassium Chloride	176	26
Eliquis	Apixaban	171	20
Metformin Hcl	Metformin Hcl	166	18
Loperamide	Loperamide Hcl	164	41
Citalopram Hbr	Citalopram Hydrobromide	161	20
Losartan Potassium	Losartan Potassium	161	18
Olanzapine	Olanzapine	161	17
Sertraline Hcl	Sertraline Hcl	161	16
Pantoprazole Sodium	Pantoprazole Sodium	147	18
Simvastatin	Simvastatin	145	18
Duloxetine Hcl	Duloxetine Hcl	122	13
Memantine Hcl	Memantine Hcl	119	15
Escitalopram Oxalate	Escitalopram Oxalate	95	13
Diclofenac Sodium	Diclofenac Sodium	92	30
Metoprolol Tartrate	Metoprolol Tartrate	87	14
Tamsulosin Hcl	Tamsulosin Hcl	87	14
Buspirone Hcl	Buspirone Hcl	82	suppressed
Jantoven	Warfarin Sodium	82	suppressed
Clopidogrel	Clopidogrel Bisulfate	79	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	suppressed
Metformin Hcl Er	Metformin Hcl	77	suppressed
Torsemide	Torsemide	76	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	68	12
Rosuvastatin Calcium	Rosuvastatin Calcium	66	suppressed
Tramadol Hcl	Tramadol Hcl	64	16
Risperidone	Risperidone	59	16
Myrbetriq	Mirabegron	58	suppressed
Latanoprost	Latanoprost	56	suppressed
Nystatin	Nystatin	55	25
Spironolactone	Spironolactone	55	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	12
Levetiracetam	Levetiracetam	50	suppressed
Allopurinol	Allopurinol	48	suppressed
Famotidine	Famotidine	46	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	31
Glipizide Er	Glipizide	43	suppressed
Meclizine Hcl	Meclizine Hcl	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	suppressed
Aripiprazole	Aripiprazole	38	suppressed
Prednisone	Prednisone	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Carvedilol	Carvedilol	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Lorazepam	Lorazepam	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Atenolol	Atenolol	31	suppressed
Cephalexin	Cephalexin	31	19
Baclofen	Baclofen	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Haloperidol	Haloperidol	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	23
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Ozempic	Semaglutide	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Klor-Con	Potassium Chloride	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Febuxostat	Febuxostat	16	suppressed
Methadone Intensol	Methadone Hcl	16	suppressed
Methimazole	Methimazole	16	suppressed
Metolazone	Metolazone	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Procto-Med Hc	Hydrocortisone	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Estradiol	Estradiol	13	suppressed
Glipizide	Glipizide	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Trospium Chloride Er	Trospium Chloride	13	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error